Cargando…
Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients
Intense label-free surface-enhanced Raman scattering (SERS) spectra of serum samples were rapidly obtained on Ag plasmonic paper substrates upon 785 nm excitation. Spectra from the hepatocellular carcinoma (HCC) patients showed consistent differences with respect to those of the control group. In pa...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892523/ https://www.ncbi.nlm.nih.gov/pubmed/33294938 http://dx.doi.org/10.1007/s00216-020-03093-7 |
_version_ | 1783652863924240384 |
---|---|
author | Gurian, Elisa Di Silvestre, Alessia Mitri, Elisa Pascut, Devis Tiribelli, Claudio Giuffrè, Mauro Crocè, Lory Saveria Sergo, Valter Bonifacio, Alois |
author_facet | Gurian, Elisa Di Silvestre, Alessia Mitri, Elisa Pascut, Devis Tiribelli, Claudio Giuffrè, Mauro Crocè, Lory Saveria Sergo, Valter Bonifacio, Alois |
author_sort | Gurian, Elisa |
collection | PubMed |
description | Intense label-free surface-enhanced Raman scattering (SERS) spectra of serum samples were rapidly obtained on Ag plasmonic paper substrates upon 785 nm excitation. Spectra from the hepatocellular carcinoma (HCC) patients showed consistent differences with respect to those of the control group. In particular, uric acid was found to be relatively more abundant in patients, while hypoxanthine, ergothioneine, and glutathione were found as relatively more abundant in the control group. A repeated double cross-validation (RDCV) strategy was applied to optimize and validate principal component analysis-linear discriminant analysis (PCA-LDA) models. An analysis of the RDCV results indicated that a PCA-LDA model using up to the first four principal components has a good classification performance (average accuracy was 81%). The analysis also allowed confidence intervals to be calculated for the figures of merit, and the principal components used by the LDA to be interpreted in terms of metabolites, confirming that bands of uric acid, hypoxanthine, ergothioneine, and glutathione were indeed used by the PCA-LDA algorithm to classify the spectra. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00216-020-03093-7. |
format | Online Article Text |
id | pubmed-7892523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-78925232021-03-03 Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients Gurian, Elisa Di Silvestre, Alessia Mitri, Elisa Pascut, Devis Tiribelli, Claudio Giuffrè, Mauro Crocè, Lory Saveria Sergo, Valter Bonifacio, Alois Anal Bioanal Chem Research Paper Intense label-free surface-enhanced Raman scattering (SERS) spectra of serum samples were rapidly obtained on Ag plasmonic paper substrates upon 785 nm excitation. Spectra from the hepatocellular carcinoma (HCC) patients showed consistent differences with respect to those of the control group. In particular, uric acid was found to be relatively more abundant in patients, while hypoxanthine, ergothioneine, and glutathione were found as relatively more abundant in the control group. A repeated double cross-validation (RDCV) strategy was applied to optimize and validate principal component analysis-linear discriminant analysis (PCA-LDA) models. An analysis of the RDCV results indicated that a PCA-LDA model using up to the first four principal components has a good classification performance (average accuracy was 81%). The analysis also allowed confidence intervals to be calculated for the figures of merit, and the principal components used by the LDA to be interpreted in terms of metabolites, confirming that bands of uric acid, hypoxanthine, ergothioneine, and glutathione were indeed used by the PCA-LDA algorithm to classify the spectra. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00216-020-03093-7. Springer Berlin Heidelberg 2020-12-08 2021 /pmc/articles/PMC7892523/ /pubmed/33294938 http://dx.doi.org/10.1007/s00216-020-03093-7 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Paper Gurian, Elisa Di Silvestre, Alessia Mitri, Elisa Pascut, Devis Tiribelli, Claudio Giuffrè, Mauro Crocè, Lory Saveria Sergo, Valter Bonifacio, Alois Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients |
title | Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients |
title_full | Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients |
title_fullStr | Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients |
title_full_unstemmed | Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients |
title_short | Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients |
title_sort | repeated double cross-validation applied to the pca-lda classification of sers spectra: a case study with serum samples from hepatocellular carcinoma patients |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892523/ https://www.ncbi.nlm.nih.gov/pubmed/33294938 http://dx.doi.org/10.1007/s00216-020-03093-7 |
work_keys_str_mv | AT gurianelisa repeateddoublecrossvalidationappliedtothepcaldaclassificationofsersspectraacasestudywithserumsamplesfromhepatocellularcarcinomapatients AT disilvestrealessia repeateddoublecrossvalidationappliedtothepcaldaclassificationofsersspectraacasestudywithserumsamplesfromhepatocellularcarcinomapatients AT mitrielisa repeateddoublecrossvalidationappliedtothepcaldaclassificationofsersspectraacasestudywithserumsamplesfromhepatocellularcarcinomapatients AT pascutdevis repeateddoublecrossvalidationappliedtothepcaldaclassificationofsersspectraacasestudywithserumsamplesfromhepatocellularcarcinomapatients AT tiribelliclaudio repeateddoublecrossvalidationappliedtothepcaldaclassificationofsersspectraacasestudywithserumsamplesfromhepatocellularcarcinomapatients AT giuffremauro repeateddoublecrossvalidationappliedtothepcaldaclassificationofsersspectraacasestudywithserumsamplesfromhepatocellularcarcinomapatients AT crocelorysaveria repeateddoublecrossvalidationappliedtothepcaldaclassificationofsersspectraacasestudywithserumsamplesfromhepatocellularcarcinomapatients AT sergovalter repeateddoublecrossvalidationappliedtothepcaldaclassificationofsersspectraacasestudywithserumsamplesfromhepatocellularcarcinomapatients AT bonifacioalois repeateddoublecrossvalidationappliedtothepcaldaclassificationofsersspectraacasestudywithserumsamplesfromhepatocellularcarcinomapatients |